SCHEMBL30135568

SCHEMBL30135568

CC(C)(C)OC(=O)CN(CCCNC(=O)OCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.51
MAPT P10636 2/20 0.49
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CCR6 P51684 1/20 0.46
PAX8 Q06710 1/20 0.46
TGM2 P21980 1/20 0.46
KEAP1 Q14145 3/20 0.46
NFE2L2 Q16236 3/20 0.46
SYK P43405 1/20 0.45
TPSAB1 Q15661 2/20 0.45
TPSD1 Q9BZJ3 2/20 0.45
TPSG1 Q9NRR2 2/20 0.45
CA14 Q9ULX7 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
FOLH1 Q04609 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
NCOR2 Q9Y618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30135570 1.00 HTT (0.51) HTTMAPTLMNASMN1; SMN2CCR6
SCHEMBL4927806 0.96 HTT (0.51) HTTMAPTLMNASMN1; SMN2CCR6
SCHEMBL9554886 0.93 SMN1; SMN2 (0.49) HTTMAPTLMNASMN1; SMN2TGM2
SCHEMBL22123600 0.89 HTT (0.53) HTTMAPTLMNASMN1; SMN2CCR6
SCHEMBL9772169 0.88 MAPT (0.55) HTTMAPTLMNASMN1; SMN2CCR6
SCHEMBL31490054 0.88 HTT (0.54) HTTMAPTLMNASMN1; SMN2TGM2
SCHEMBL13664877 0.87 HTT (0.52) HTTMAPTLMNASMN1; SMN2CCR6
SCHEMBL9766146 0.87 CCR6 (0.52) HTTMAPTLMNASMN1; SMN2CCR6
SCHEMBL16596906 0.86 MAPT (0.51) HTTMAPTLMNASMN1; SMN2CCR6
SCHEMBL29924523 0.86 HTT (0.50) HTTMAPTLMNASMN1; SMN2CCR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373529-A1 FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF 3B Pharmaceuticals GmbH (DE) 2024-05-29 EP disclosed
WO-2023002045-A1 FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2023-01-26 WO disclosed